BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 94 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 2.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $544,000 | +1500.0% | 321,602 | +2501.3% | 0.00% | – |
| Q1 2022 | $34,000 | -54.1% | 12,363 | -10.6% | 0.00% | – |
| Q4 2021 | $74,000 | -64.9% | 13,825 | -44.6% | 0.00% | – |
| Q3 2021 | $211,000 | -85.2% | 24,963 | -78.6% | 0.00% | -100.0% |
| Q2 2021 | $1,424,000 | +371.5% | 116,845 | +837.4% | 0.00% | – |
| Q1 2021 | $302,000 | -30.6% | 12,465 | -8.1% | 0.00% | – |
| Q4 2020 | $435,000 | +45.0% | 13,560 | +36.7% | 0.00% | – |
| Q3 2020 | $300,000 | -54.6% | 9,923 | -36.7% | 0.00% | -100.0% |
| Q2 2020 | $661,000 | +94.4% | 15,670 | +15.0% | 0.00% | – |
| Q1 2020 | $340,000 | – | 13,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |